SB 6292 Washington Senate · 2025-2026 Regular Session

Establishing a joint legislative executive committee on health care financing.

SB 6292 establishes a joint committee to study health care financing in Washington state, directly involving state legislators, executive branch agencies (like Health Care Authority and Insurance Commissioner), and tribal representatives. The committee will investigate specific strategies to improve affordability and access - such as prescription drug pricing, payment models, and federal fund coordination - and must deliver preliminary and final reports by 2027. It expires on January 1, 2028, and will not enact new laws but develop recommendations for the legislature. The bill does not change current policies but creates a structured process for analyzing health care financing challenges.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2026

Committee Review

Floor Vote

Governor

Introduced Jan 22, 2026 Last action Feb 4, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Bill → Substitute Bill · 6 edits

MODERATE

The bill was updated from an original version to a substitute version, shifting the focus from general financing strategies to specific goals like preserving health insurance market stability and lowering drug prices. The committee's duties were expanded to include consulting with additional experts and coordinating with existing health boards, while the list of topics to investigate was broadened to cover more specific payment models and administrative opportunities.

Scope change

The scope of the committee's work was expanded to include specific market stability goals and coordination with other state health boards, and the list of required expert consultations was broadened.

REQUIREMENT

The committee's mission was updated to explicitly include preserving the stability of individual, small group, and large group health insurance markets.

The list of topics for investigation was expanded to include health plan pricing strategies, services payment methodologies, and administrative simplification for state-purchased programs.

A new requirement was added for the committee to coordinate with the universal health care commission, the health care cost transparency board, and the prescription drug affordability board.

The list of required expert consultants was expanded to include health care purchasers and the leadership of the legislature's standing fiscal committees.

A specific requirement to identify at least two components of the health system needing direct state action was removed and replaced with a broader category.

TECHNICAL

Minor wording changes were made to terms like 'health carriers' and 'consumer cost sharing' to improve clarity.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 4, 2026

Committee

On motion, referred to Ways & Means.

upper

Feb 3, 2026

Upper · Passed

Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM.

upper

Jan 29, 2026

Upper · Passed

Public hearing in the Senate Committee on Health & Long-Term Care at 8:00 AM.

upper

1 primary · 3 co-sponsors